UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2020 | 2021-02-27 | Future report Set alerts | |
| Q2 2020 | 2020-08-06 | -0.37 | 0.00 |
| Q1 2020 | 2020-05-07 | -0.59 | -0.59 |
| Q4 2019 | 2020-02-25 | -0.83 | -0.83 |
| Q3 2019 | 2019-11-07 | -0.99 | -0.99 |
| Q2 2019 | 2019-08-08 | -0.90 | -0.90 |
| Q1 2019 | 2019-05-09 | -1.08 | -1.08 |
| Q4 2018 | 2019-03-04 | -1.06 | -1.06 |
| Q3 2018 | 2018-11-01 | -1.22 | -1.22 |
| Q2 2018 | 2018-08-02 | -1.26 | -1.26 |
| 2016-06-28 | Reiterated Rating | Noble Financial | Buy | $25.00 |
| 2016-06-23 | Reiterated Rating | Mizuho | Buy | |
| 2016-06-22 | Reiterated Rating | Credit Suisse | Buy | |
| 2016-06-22 | Reiterated Rating | Credit Suisse Group AG | Buy | |
| 2016-06-17 | Initiated Coverage | Noble Financial | Buy | $25.00 |
| 2016-06-16 | Upgrade | Mizuho | Neutral to Buy | $22.00 |
| 2016-06-15 | Reiterated Rating | JMP Securities | Buy | |
| 2016-06-14 | Reiterated Rating | Piper Jaffray | Overweight | $44.00 |
| 2016-06-14 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $44.00 |
| 2016-06-13 | Reiterated Rating | Mizuho | Hold | |
| 2016-05-12 | Lower Price Target | Mizuho | Neutral | $17.00 to $16.00 |
| 2016-05-12 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-04-28 | Boost Price Target | Mizuho | Neutral | $14.00 to $17.00 |
| 2016-04-01 | Initiated Coverage | JMP Securities | Outperform | $29.00 |
| 2016-02-25 | Reiterated Rating | Mizuho | Neutral | $26.00 to $14.00 |
| 2016-01-26 | Reiterated Rating | Aegis | Buy | |
| 2016-01-19 | Initiated Coverage | Cowen and Company | Outperform | $45.00 |
| 2016-01-19 | Initiated Coverage | Mizuho | Neutral | $26.00 |
| 2016-01-12 | Reiterated Rating | Piper Jaffray | Overweight | $37.00 to $44.00 |
| 2015-12-31 | Reiterated Rating | Credit Suisse | Buy | |
| 2015-12-30 | Reiterated Rating | Aegis | Buy | |
| 2015-12-29 | Reiterated Rating | Needham & Company LLC | Buy | |
| 2015-12-25 | Reiterated Rating | Credit Suisse | Buy | |
| 2015-12-24 | Boost Price Target | Credit Suisse | Outperform | $35.00 to $37.00 |
| 2015-12-24 | Boost Price Target | Needham & Company LLC | $38.00 | |
| 2015-12-24 | Reiterated Rating | Aegis | Buy | $29.00 |
| 2015-12-23 | Reiterated Rating | Needham & Company LLC | Buy | $33.00 to $38.00 |
| 2015-09-22 | Initiated Coverage | Aegis | Buy | $29.00 |
| 2015-09-11 | Reiterated Rating | William Blair | Outperform | $35.00 |
| 2014-11-07 | Reiterated Rating | Credit Suisse | Outperform | $30.00 to $27.00 |
| 2014-08-12 | Boost Price Target | Credit Suisse | $26.00 to $30.00 | |
| 2014-05-05 | Initiated Coverage | William Blair | Outperform | $35.00 |
| 2014-05-05 | Initiated | Needham | Buy | $33 |
| 2014-05-05 | Initiated Coverage | Needham & Company LLC | Buy | $33.00 |
| 2014-05-05 | Initiated Coverage | Credit Suisse | Outperform | $26.00 |
| 2014-05-05 | Initiated Coverage | Piper Jaffray | Overweight | $32.00 |
| 2016-06-28 | Reiterated Rating | Noble Financial | Buy | $25.00 |
| 2016-06-23 | Reiterated Rating | Mizuho | Buy | |
| 2016-06-22 | Reiterated Rating | Credit Suisse | Buy | |
| 2016-06-22 | Reiterated Rating | Credit Suisse Group AG | Buy | |
| 2016-06-17 | Initiated Coverage | Noble Financial | Buy | $25.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ADMS 62 funds of 2184 total. Show all
| Fund name | Ticker shares |
|---|---|
| MDV Management Company, L.L.C. | 4.58M |
| ARMISTICE CAPITAL, LLC | 2.74M |
| Opaleye Management Inc. | 0.96M |
| Vanguard Group, Inc | 0.93M |
| RENAISSANCE TECHNOLOGIES LLC | 0.86M |
| BlackRock Fund Advisors | 0.85M |
| Stonepine Capital Management, LLC | 0.76M |
| EMERALD ADVISERS INC/PA | 0.67M |
| EMERALD MUTUAL FUND ADVISERS TRUST | 0.62M |
| BlackRock Inc. | 0.60M |
| Nuveen Asset Management, LLC | 0.37M |
| DELTEC ASSET MANAGEMENT LLC | 0.36M |
| BlackRock Institutional Trust Company, N.A. | 0.35M |
| MORGAN STANLEY | 0.35M |
| BRIDGEWAY CAPITAL MANAGEMENT INC | 0.18M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| GREAT POINT PARTNERS LLC | 13.23% (2216351) | ADMS / INFU / |
| aeris Capital Equity Investments, L.P. | 9.92% (1662128) | ADMS / |
| MDV IX LP | 1.72% (287992) | ADMS / |
| Ericson William W. | 1.72% (287992) | ADMS / FUEL / PACB / |
| Went Gregory T Chief Executive Officer | 1.09% (182610) | ADMS / |
| KING RICHARD Chief Operating Officer | 0.30% (50661) | ACRX / ADMS / |
| LIEBERBURG IVAN M | 0.29% (48000) | ADMS / |
| BOOTH RICHARD H | 0.27% (45778) | ADMS / NU / THG / |
| Rhodes Jennifer J General Counsel | 0.20% (34128) | ADMS / MDVN / |
| MERRIWEATHER ALFRED G Chief Financial Officer | 0.16% (27125) | ADMS / |
| MDV VII LP | 0.15% (25661) | ADMS / PFPT / |
| Patni Rajiv Chief Medical Officer | 0.13% (21515) | ADMS / OCRX / |
| Prentiss Christopher B Chief Accounting Officer | 0.11% (17758) | ADMS / |
| DAWSON WILLIAM J Chief Financial Officer | 0.09% (14284) | ADMS / MGRC / |
| McClure Natalie SVP, Product Development | 0.05% (8340) | ADMS / |
| MAHONEY DAVID L | 0.02% (2628) | ADMS / CORT / SYMC / |
| DAG Ventures Management III, LLC | 0.01% (1474) | ADMS / YUME / |
Undercovermarket.com